TY - JOUR
T1 - Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1
AU - White, Tommy E.
AU - Brandariz-Nuñez, Alberto
AU - Carlos Valle-Casuso, Jose
AU - Amie, Sarah
AU - Nguyen, Laura
AU - Kim, Baek
AU - Brojatsch, Jurgen
AU - Diaz-Griffero, Felipe
N1 - Funding Information:
This work was funded by the NIH No. R01 AI087390 to F.D.-G, and a K99/R00 Pathway to Independence Award to F.D.-G. from the National Institutes of Health No. 4R00MH086162-02 .
PY - 2013/2/5
Y1 - 2013/2/5
N2 - The human SAMHD1 protein is a novel retroviral restriction factor expressed in myeloid cells. Previous work has correlated the deoxynucleotide triphosphohydrolase activity of SAMHD1 with its ability to block HIV-1 and SIVmac infection. SAMHD1 is comprised of the sterile alpha motif (SAM) and histidine-aspartic (HD) domains; however the contribution of these domains to retroviral restriction is not understood. Mutagenesis and deletion studies revealed that expression of the sole HD domain of SAMHD1 is sufficient to achieve potent restriction of HIV-1 and SIVmac. We demonstrated that the HD domain of SAMHD1 is essential for the ability of SAMHD1 to oligomerize by using a biochemical assay. In agreement with previous observations, we mapped the RNA-binding ability of SAMHD1 to the HD domain. We also demonstrated a direct interaction of SAMHD1 with RNA by using enzymatically-active purified SAMHD1 protein from insect cells. Interestingly, we showed that double-stranded RNA inhibits the enzymatic activity of SAMHD1 in vitro suggesting the possibility that RNA from a pathogen might modulate the enzymatic activity of SAMHD1 in cells. By contrast, we found that the SAM domain is dispensable for retroviral restriction, oligomerization and RNA binding. Finally we tested the ability of SAMHD1 to block the infection of retroviruses other than HIV-1 and SIVmac. These results showed that SAMHD1 blocks infection of HIV-2, feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV), Equine infectious anemia virus (EIAV), N-tropic murine leukemia virus (N-MLV), and B-tropic murine leukemia virus (B-MLV).
AB - The human SAMHD1 protein is a novel retroviral restriction factor expressed in myeloid cells. Previous work has correlated the deoxynucleotide triphosphohydrolase activity of SAMHD1 with its ability to block HIV-1 and SIVmac infection. SAMHD1 is comprised of the sterile alpha motif (SAM) and histidine-aspartic (HD) domains; however the contribution of these domains to retroviral restriction is not understood. Mutagenesis and deletion studies revealed that expression of the sole HD domain of SAMHD1 is sufficient to achieve potent restriction of HIV-1 and SIVmac. We demonstrated that the HD domain of SAMHD1 is essential for the ability of SAMHD1 to oligomerize by using a biochemical assay. In agreement with previous observations, we mapped the RNA-binding ability of SAMHD1 to the HD domain. We also demonstrated a direct interaction of SAMHD1 with RNA by using enzymatically-active purified SAMHD1 protein from insect cells. Interestingly, we showed that double-stranded RNA inhibits the enzymatic activity of SAMHD1 in vitro suggesting the possibility that RNA from a pathogen might modulate the enzymatic activity of SAMHD1 in cells. By contrast, we found that the SAM domain is dispensable for retroviral restriction, oligomerization and RNA binding. Finally we tested the ability of SAMHD1 to block the infection of retroviruses other than HIV-1 and SIVmac. These results showed that SAMHD1 blocks infection of HIV-2, feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV), Equine infectious anemia virus (EIAV), N-tropic murine leukemia virus (N-MLV), and B-tropic murine leukemia virus (B-MLV).
KW - DNTPase
KW - HD domain
KW - HIV-1
KW - RNA binding
KW - Restriction
KW - SAMHD1
UR - http://www.scopus.com/inward/record.url?scp=84872182254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872182254&partnerID=8YFLogxK
U2 - 10.1016/j.virol.2012.10.029
DO - 10.1016/j.virol.2012.10.029
M3 - Article
C2 - 23158101
AN - SCOPUS:84872182254
SN - 0042-6822
VL - 436
SP - 81
EP - 90
JO - Virology
JF - Virology
IS - 1
ER -